Berenguer-Ruiz, Leticia
Gimenez-Martinez, Juana
Palazón-Bru, Antonio
Sempere, Angel Perez
Article History
Received: 17 March 2019
Revised: 24 June 2019
Accepted: 25 June 2019
First Online: 29 June 2019
Compliance with ethical standards
:
: Leticia Berenguer-Ruiz has received personal compensation for consulting, serving on a scientific advisory board or speaking with Almirall, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis and Teva. Juana Gimenez-Martinez has received speaker honoraria from Almirall, Biogen Idec and Sanofi-Aventis. Antonio Palazón-Bru reports no disclosures. Angel P. Sempere has received personal compensation for consulting, serving on a scientific advisory board or speaking with Almirall, Biogen Idec, Bayer Schering Pharma, Merck Serono, Novartis, Roche, Sanofi-Aventis and Teva.
: The authors confirm that this article complies with ethical standards.